Inhibition of NF-κB activation by a dominant-negative mutant of IκBα

Molecular Immunology

Volumn 33, Issue 1, 1996, Pages 57-61

  Chen, Chao Guang ^a   Malliaros, Jim ^a   Katerelos, Marina ^a   D'apice, Anthony J F ^a   Pearse, Martin J ^a  

^a ST VINCENT S HOSPITAL   (Australia)

Author keywords

I B ; NF B; NF B activation; Phosphorylation site

Indexed keywords

TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR ALPHA; CASEIN KINASE II; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; ONCOPROTEIN; PROTEIN SERINE THREONINE KINASE; RECOMBINANT PROTEIN; RELB PROTEIN, MOUSE; TRANSCRIPTION FACTOR RELB;

ANIMAL CELL; ARTICLE; GENE EXPRESSION; IMMUNOBLOTTING; MOUSE; MUTANT; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; ANIMAL; CHEMISTRY; DOMINANT GENE; DRUG ANTAGONISM; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; PHOSPHORYLATION; SITE DIRECTED MUTAGENESIS; SWINE;

ANIMALIA; SUIDAE;

ANIMALS; CASEIN KINASE II; GENES, DOMINANT; MICE; MUTAGENESIS, SITE-DIRECTED; NF-KAPPA B; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; RECOMBINANT PROTEINS; SWINE; TRANSCRIPTION FACTOR RELB; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 0029664476     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/0161-5890(95)00128-X     Document Type: Article

References (22)

1. Alkalay I., Yaron A., Hatzubai A., Jung S., Avraham A., Grelitz O., Pashut-Lavon I. and Ben-Neriah Y. (1995) In vivo stimulation of IκB phosphorylation is not sufficient to activate NF-κB. Mol. Cell. Biol. 15, 1294-1301.
2. Beg A. A., Finco T. S., Nantermet P. V. and Baldwin A. S. (1993) Tumor necrosis factor and interleukin-1 lead to phosphorylation and loss of IκBα: a mechanism for NF-κB activation. Mol. Cell. Biol. 13, 3301-3310. s
3. Beg A. A., Ruben S. M., Scheinman R. I., Haskill S., Rosen C. A. and Baldwin A. S. (1992) IκB interacts with the nuclear localization sequences of the subunits of NF-κB: a mechanism for cytoplasmic retention. Gene Dev. 6, 1899-191 3.
4. Booyse F. M., Quarfoot A. J., Bell S., Fass D. N., Lewis J. C., Mann K. G. and Bowie E. J. (1977) Cultured aortic endothelial cells from pigs with von Willebrand disease. Proc. natn. Acad. Sci. USA 74, 5702-5706.
5. Brown K., Gerstberger S., Carlson L., Franzoso G. and Siebenlist U. (1995) Control of IκBα proteolysis by site-specific signal-induced phosphorylation. Science 267, 1485-1488.
6. Cordle S. R., Donald R., Read M. A. and Hawiger J. (1993) Lipopolysaccharide induces phosphorylation of MAD-3 and activation of c-Rel and related NF-κB proteins in human monocytic THP-1 cells. J. Biol. Chem. 268, 11803-11810.
7. de Martin R., Vanhove B., Cheng Q., Hofer E., Csizmadia V., Winkler H. and Bach F. H. (1993) Cytokine-inducible expression in endothelial cells of an IκBα-like gene is regulated by NF-κB. EMBO J. 12, 2773-2779.
8. Didonato J. A., Mercurio F. and Karin M. (1995) Phosphorylation of IκBα precedes but is not sufficient for its dissociation from NF-κB. Mol. Cell. Biol. 15, 1302-1311.
9. Finco T. S., Beg A. A. and Baldwin A. S. (1994) Inducible phosphorylation of IκBα is not sufficient for its dissociation from NF-κB and is inhibited by protease inhibitors. Proc. natn. Acad. Sci. USA 91, 11884-11888.
10. Gerondakis S. and Grumont R. (1994) NF-κB: a bridge between cytoplasm and nucleus. Today's Life Sci. 6, 24-28.
11. Grilli M., Chiu J.-S. and Lenardo M. (1993) NF-κB and Rel: participants in a multiform transcriptional regulatory system. Int. Rev. Cytol. 143, 1-62.
12. Kingston R. E. (1988) Current Protocols in Molecular Biology. Greene, New York.
13. Lenardo M. J. and Baltimore D. (1989) NF-κB: a pleiotropic mediator of inducible and tissue-specific gene control. Cell 58, 227-229.
14. Lin Y.-C., Brown K. and Siebenlist U. (1995) Activation of NF-κB requires proteolysis of the inhibitor IκBα: signal-induced phosphorylation of IκBα alone does not release active NF-κB. Proc. natn. Acad. Sci. USA 92, 552-556.
15. Liou H.C. and Baltimore D. (1993) Regulation of the NF-κB/Rel transcription factor and IκB inhibitor system. Current Opin. Cell Biol. 5, 477-487.
16. Luckow B. and Schütz G. (1987) CAT constructs with multiple unique restriction sites for the functional analysis of eukaryotic promoters and regulatory elements. Nucleic Acids Res. 15, 5400.
17. Mellits K. H., Hay R. T. and Goodbourn S. (1993) Proteolytic degradation of MAD-3 (IκBα) and enhanced processing of the NF-κB precursor p105 are obligatory steps in the activation of NF-κB. Nucleic Acids Res. 21, 5059-5066.
18. Miyamoto S., Maki M., Schmitt M. J., Hatanaka M. and Verma I. M. (1994) Tumor necrosis factor α-induced phosphorylation of IκBα is a signal for its degradation but not dissociation from NF-κB. Proc. natn. Acad. Sci. USA 91, 12740-12744.
19. Nolan G. P., Ghosh S., Liou H.-C., Tempst P. and Baltimore D. (1991) DNA binding and IκB inhibition of the cloned p65 subunit of NF-κB, a rel-related polypeptide. Cell 64, 961-969.
20. Palombella V. J., Rando O. J., Goldberg A. L. and Maniatis T. (1994) The ubiquitin-proteasome pathway is required for processing the NF-κB1 precursor protein and the activation of NF-κB. Cell 78, 773-785.
21. Sen R. and Baltimore D. (1986) Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell 46, 705-716.
22. Traenckner E. B.-M, Wilk S. and Baeuerle P. A. (1994) A proteasome inhibitor prevents activation of NF-κB and stabilizes a newly phosphorylated form of IκBα that is still bound to NF-κB. EMBO J. 13, 5433-5441.